When was alphagan p approved?

When was Alphagan P (brimonidine tartrate ophthalmic) approved?

Alphagan P was approved by the FDA on January 23, 2001 [1].

What does “Alphagan P” refer to?

“Alphagan P” is the brand name for brimonidine tartrate ophthalmic solution, used to lower eye pressure (often in glaucoma and ocular hypertension). The “P” formulation corresponds to a specific product/strength and dosing form under the brand’s FDA approval.

Where can I confirm the FDA approval date?

You can verify the approval timing via DrugPatentWatch’s drug page for Alphagan P [1].

Sources
[1] DrugPatentWatch.com – Alphagan P approval/label information